Ethicon and Focal develop cardiovascular sealant:
This article was originally published in Clinica
Johnson & Johnson subsidiary Ethicon and Focal are to jointly develop and market a cardiovascular version of the surgical sealant FocalSeal. The companies are already working on pulmonary and neural versions under an agreement reached last year. FocalSeal is approved outside North America for lung indications and is distributed by Ethicon under the brand name AdvaSeal.